Rising Menstrual Product Prices Squeeze Consumers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 22 2026
0mins
Source: CNBC
- Price Surge: The average price of menstrual products has risen nearly 40% since 2020, from approximately $5.37 to $7.43 per unit, squeezing consumer budgets and impacting purchasing decisions.
- Sales Dynamics: While dollar sales of menstrual products grew nearly 30% during the same period, sales volume has decreased by about 6% since 2022, indicating a trend of consumers seeking alternatives due to high prices.
- Tariff Impact: In 2025, the U.S. collected $115 million in tariffs on menstrual products containing cotton, a significant increase from $42 million in 2020, further exacerbating the economic burden on consumers.
- Rise of Reusables: An increasing number of consumers are turning to reusable menstrual products, such as cups and underwear, due to their environmental benefits and lower long-term costs, which is expected to continue exerting pressure on traditional single-use product sales.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PG
Wall Street analysts forecast PG stock price to rise
17 Analyst Rating
10 Buy
7 Hold
0 Sell
Moderate Buy
Current: 143.400
Low
150.00
Averages
164.50
High
180.00
Current: 143.400
Low
150.00
Averages
164.50
High
180.00
About PG
The Procter & Gamble Company is focused on providing branded consumer packaged goods to consumers across the world. The Company’s segments include Beauty, Grooming, Health Care, Fabric & Home Care and Baby, Feminine & Family Care. The Company’s products are sold in approximately 180 countries and territories primarily through mass merchandisers, e-commerce, including social commerce channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. It also sells direct to individual consumers. It has operations in approximately 70 countries. It offers products under brands, such as Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Ariel, Downy, Gain, Tide, Always, Always Discreet, Tampax, Bounty and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Stable Dividend Growth in Consumer Staples Stocks
- Coca-Cola's Dividend Growth: Coca-Cola approved its 64th consecutive annual dividend increase in February, raising the annual payout from $2.04 to $2.12 per share, demonstrating strong pricing power and high gross margins despite modest growth risks in developed markets.
- Procter & Gamble's Consistency: Procter & Gamble declared its 69th consecutive annual dividend increase in April, supported by a portfolio of leading brands across various categories, ensuring over 130 years of dividend payments and showcasing predictable free cash flow and ongoing investment capabilities.
- Colgate's Resilience: Colgate raised its quarterly dividend in March, continuing a long streak of payout growth, benefiting from its strong market position in oral care and growth potential in emerging markets, which helps it adapt to economic fluctuations.
- Walmart's Advertising Revenue: Walmart extended its dividend growth streak to 53 years in February, increasing its quarterly payout to $0.248 per share; while the yield is modest, its advertising business generates approximately $6.4 billion in revenue, indicating strong operating leverage and sustained market competitiveness.
See More
Reliable Dividend Growth in Consumer Staples
- Coca-Cola's Sustained Growth: The Coca-Cola Company approved its 64th consecutive annual dividend increase in February, raising the annual payout from $2.04 to $2.12 per share, reflecting its strong pricing power and high gross margins within a global network of independent bottlers, despite modest volume growth in developed markets.
- Procter & Gamble's Cash Flow Stability: Procter & Gamble declared its 69th consecutive annual dividend increase in April, supported by a portfolio of leading brands across various categories, ensuring predictable free cash flow that covers dividends, buybacks, and product development funding needs.
- Colgate's Resilience: Colgate-Palmolive raised its quarterly dividend in March, benefiting from the recession-resistant nature of toothpaste and oral care products, while its exposure to emerging markets provides volume growth advantages over mature U.S. competitors.
- Walmart's Advertising Revenue Growth: Walmart extended its dividend growth streak to 53 years in February, increasing its quarterly payout to $0.248 per share, with its advertising business generating approximately $6.4 billion in revenue, showcasing operational leverage and success in its membership program.
See More
Three Dividend Growth Stocks to Consider Amid Market Uncertainty
- AbbVie's Dividend King Status: AbbVie has maintained a dividend increase for over 50 years since its spin-off from Abbott, currently offering a 3.2% yield, significantly higher than the S&P 500's 1.1%, showcasing its reliability as a dividend payer, making it an attractive option for income-seeking investors.
- Procter & Gamble's Market Edge: As one of the largest consumer staples companies globally, Procter & Gamble's products maintain strong demand regardless of economic conditions, with a 3% dividend yield exceeding the industry average of 2%, and its current valuation below five-year averages indicates an attractive buying opportunity for long-term investors.
- Enterprise Products' Steady Growth: While not yet a Dividend King, Enterprise Products has increased its distribution for 27 consecutive years, reflecting stability in the energy infrastructure sector, with a 5.5% distribution yield and a 1.7x cash flow coverage reducing the risk of cuts, appealing to high-yield investors.
- Investor Risk Aversion Strategy: As market uncertainty rises, investors often shift towards high-dividend stocks, making AbbVie, Procter & Gamble, and Enterprise Products ideal choices due to their strong business fundamentals and stable dividend histories, helping investors maintain income in volatile markets.
See More
Three High-Yield Dividend Stocks to Consider
- AbbVie's Appeal: AbbVie, with over five decades of dividend growth, offers an attractive 3.2% yield, significantly higher than the S&P 500's 1.1% and the pharma sector's 0.7%, making it a prime choice for investors shifting from tech, especially as new drugs like Skyrizi and Rinvoq show promise against generic competition.
- Procter & Gamble's Market Position: Procter & Gamble, one of the largest consumer goods companies globally, boasts a 3% dividend yield above the industry average of 2%, and its essential products ensure stable demand even during market fluctuations, making it an attractive buy at current price levels, with a $10,000 investment allowing for approximately 70 shares.
- Enterprise Products' Stability: Although Enterprise Products Partners has not reached Dividend King status, its 27 consecutive years of distribution growth highlight its reliability in the energy infrastructure sector, with a high 5.5% yield and a 1.7x cash flow coverage reducing the risk of cuts, appealing to income-focused investors.
- Risk-Averse Investment Strategy: As market uncertainties rise, investors often gravitate towards high-yield dividend stocks, making AbbVie, Procter & Gamble, and Enterprise Products ideal candidates for those looking to rotate out of tech stocks, providing a steady income stream backed by strong business fundamentals.
See More
Investors Shift Focus to High-Yield Dividend Stocks
- AbbVie's Reliable Income: AbbVie, a pharmaceutical giant, has increased its dividends for over fifty years since its spin-off from Abbott, currently offering a 3.2% yield, significantly higher than the S&P 500's 1.1%, making it a reliable choice for investors shifting to high-yield stocks.
- Procter & Gamble's Market Position: As one of the largest consumer staples companies globally, Procter & Gamble's products are considered necessities, and its current 3% dividend yield exceeds the industry average of 2%, making it attractive during economic uncertainty despite market fluctuations.
- Enterprise's Growth Potential: While not yet a Dividend King, Enterprise has increased its distributions for 27 consecutive years, boasting a 5.5% yield and a 1.7x cash flow coverage, which mitigates the risk of dividend cuts, appealing to income-seeking investors.
- Investor Risk Preference Shift: As market risk preferences change, investors often gravitate towards high-yield stocks, with AbbVie, Procter & Gamble, and Enterprise being preferred options due to their strong business fundamentals and consistent dividend histories when rotating out of tech stocks.
See More
Investment Value Analysis of Dividend Stocks
- Coca-Cola's Brand Strength: Ranked as the sixth most valuable brand by Forbes in 2020, Coca-Cola reported a 13% increase in Coca-Cola Zero Sugar volume in Q1 2026, demonstrating its strong brand influence, with expected organic sales growth between 4% and 5% for 2026, maintaining profitability guidance despite inflationary pressures.
- Procter & Gamble's Steady Revenue: In Q3 of fiscal 2026, Procter & Gamble achieved revenue of $21.2 billion, exceeding expectations of $20.5 billion, with net income rising to $3.9 billion, reflecting its strong market position and profitability, alongside a 3% dividend yield after 70 consecutive years of increases.
- Johnson & Johnson's Successful Transformation: After spinning off its consumer healthcare segment, Johnson & Johnson focuses on pharmaceuticals and medical devices, with Q1 sales of blood cancer drug Darzalex reaching $4 billion, surpassing analyst estimates, indicating strong growth potential in key business areas despite challenges from patent expirations.
- Attraction of Dividend Kings: Coca-Cola, Procter & Gamble, and Johnson & Johnson are all Dividend Kings, having increased dividends for 64, 70, and 64 years respectively, appealing to long-term investors, especially as stable dividend yields provide reliable cash flow amid economic uncertainty.
See More
Stable Dividend Growth in Consumer Staples Stocks
- Coca-Cola's Dividend Growth: Coca-Cola approved its 64th consecutive annual dividend increase in February, raising the annual payout from $2.04 to $2.12 per share, demonstrating strong pricing power and high gross margins despite modest growth risks in developed markets.
- Procter & Gamble's Consistency: Procter & Gamble declared its 69th consecutive annual dividend increase in April, supported by a portfolio of leading brands across various categories, ensuring over 130 years of dividend payments and showcasing predictable free cash flow and ongoing investment capabilities.
- Colgate's Resilience: Colgate raised its quarterly dividend in March, continuing a long streak of payout growth, benefiting from its strong market position in oral care and growth potential in emerging markets, which helps it adapt to economic fluctuations.
- Walmart's Advertising Revenue: Walmart extended its dividend growth streak to 53 years in February, increasing its quarterly payout to $0.248 per share; while the yield is modest, its advertising business generates approximately $6.4 billion in revenue, indicating strong operating leverage and sustained market competitiveness.
See More
Reliable Dividend Growth in Consumer Staples
- Coca-Cola's Sustained Growth: The Coca-Cola Company approved its 64th consecutive annual dividend increase in February, raising the annual payout from $2.04 to $2.12 per share, reflecting its strong pricing power and high gross margins within a global network of independent bottlers, despite modest volume growth in developed markets.
- Procter & Gamble's Cash Flow Stability: Procter & Gamble declared its 69th consecutive annual dividend increase in April, supported by a portfolio of leading brands across various categories, ensuring predictable free cash flow that covers dividends, buybacks, and product development funding needs.
- Colgate's Resilience: Colgate-Palmolive raised its quarterly dividend in March, benefiting from the recession-resistant nature of toothpaste and oral care products, while its exposure to emerging markets provides volume growth advantages over mature U.S. competitors.
- Walmart's Advertising Revenue Growth: Walmart extended its dividend growth streak to 53 years in February, increasing its quarterly payout to $0.248 per share, with its advertising business generating approximately $6.4 billion in revenue, showcasing operational leverage and success in its membership program.
See More
Three Dividend Growth Stocks to Consider Amid Market Uncertainty
- AbbVie's Dividend King Status: AbbVie has maintained a dividend increase for over 50 years since its spin-off from Abbott, currently offering a 3.2% yield, significantly higher than the S&P 500's 1.1%, showcasing its reliability as a dividend payer, making it an attractive option for income-seeking investors.
- Procter & Gamble's Market Edge: As one of the largest consumer staples companies globally, Procter & Gamble's products maintain strong demand regardless of economic conditions, with a 3% dividend yield exceeding the industry average of 2%, and its current valuation below five-year averages indicates an attractive buying opportunity for long-term investors.
- Enterprise Products' Steady Growth: While not yet a Dividend King, Enterprise Products has increased its distribution for 27 consecutive years, reflecting stability in the energy infrastructure sector, with a 5.5% distribution yield and a 1.7x cash flow coverage reducing the risk of cuts, appealing to high-yield investors.
- Investor Risk Aversion Strategy: As market uncertainty rises, investors often shift towards high-dividend stocks, making AbbVie, Procter & Gamble, and Enterprise Products ideal choices due to their strong business fundamentals and stable dividend histories, helping investors maintain income in volatile markets.
See More
Three High-Yield Dividend Stocks to Consider
- AbbVie's Appeal: AbbVie, with over five decades of dividend growth, offers an attractive 3.2% yield, significantly higher than the S&P 500's 1.1% and the pharma sector's 0.7%, making it a prime choice for investors shifting from tech, especially as new drugs like Skyrizi and Rinvoq show promise against generic competition.
- Procter & Gamble's Market Position: Procter & Gamble, one of the largest consumer goods companies globally, boasts a 3% dividend yield above the industry average of 2%, and its essential products ensure stable demand even during market fluctuations, making it an attractive buy at current price levels, with a $10,000 investment allowing for approximately 70 shares.
- Enterprise Products' Stability: Although Enterprise Products Partners has not reached Dividend King status, its 27 consecutive years of distribution growth highlight its reliability in the energy infrastructure sector, with a high 5.5% yield and a 1.7x cash flow coverage reducing the risk of cuts, appealing to income-focused investors.
- Risk-Averse Investment Strategy: As market uncertainties rise, investors often gravitate towards high-yield dividend stocks, making AbbVie, Procter & Gamble, and Enterprise Products ideal candidates for those looking to rotate out of tech stocks, providing a steady income stream backed by strong business fundamentals.
See More
Investors Shift Focus to High-Yield Dividend Stocks
- AbbVie's Reliable Income: AbbVie, a pharmaceutical giant, has increased its dividends for over fifty years since its spin-off from Abbott, currently offering a 3.2% yield, significantly higher than the S&P 500's 1.1%, making it a reliable choice for investors shifting to high-yield stocks.
- Procter & Gamble's Market Position: As one of the largest consumer staples companies globally, Procter & Gamble's products are considered necessities, and its current 3% dividend yield exceeds the industry average of 2%, making it attractive during economic uncertainty despite market fluctuations.
- Enterprise's Growth Potential: While not yet a Dividend King, Enterprise has increased its distributions for 27 consecutive years, boasting a 5.5% yield and a 1.7x cash flow coverage, which mitigates the risk of dividend cuts, appealing to income-seeking investors.
- Investor Risk Preference Shift: As market risk preferences change, investors often gravitate towards high-yield stocks, with AbbVie, Procter & Gamble, and Enterprise being preferred options due to their strong business fundamentals and consistent dividend histories when rotating out of tech stocks.
See More
Investment Value Analysis of Dividend Stocks
- Coca-Cola's Brand Strength: Ranked as the sixth most valuable brand by Forbes in 2020, Coca-Cola reported a 13% increase in Coca-Cola Zero Sugar volume in Q1 2026, demonstrating its strong brand influence, with expected organic sales growth between 4% and 5% for 2026, maintaining profitability guidance despite inflationary pressures.
- Procter & Gamble's Steady Revenue: In Q3 of fiscal 2026, Procter & Gamble achieved revenue of $21.2 billion, exceeding expectations of $20.5 billion, with net income rising to $3.9 billion, reflecting its strong market position and profitability, alongside a 3% dividend yield after 70 consecutive years of increases.
- Johnson & Johnson's Successful Transformation: After spinning off its consumer healthcare segment, Johnson & Johnson focuses on pharmaceuticals and medical devices, with Q1 sales of blood cancer drug Darzalex reaching $4 billion, surpassing analyst estimates, indicating strong growth potential in key business areas despite challenges from patent expirations.
- Attraction of Dividend Kings: Coca-Cola, Procter & Gamble, and Johnson & Johnson are all Dividend Kings, having increased dividends for 64, 70, and 64 years respectively, appealing to long-term investors, especially as stable dividend yields provide reliable cash flow amid economic uncertainty.
See More
